← All Topics / ade

FDA ADE reports for Spinosad (spinosyn ectoparasiticide (flea)) — total reports, species & reaction breakdown

ade_spinosad_adverse_events

ade 205 tok en 2026-07-21

Spinosad — FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-21. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Spinosad is a spinosyn ectoparasiticide (flea).

Total reports

Spinosad: 212330

Reports by species (top entries)

  • Dog 185564
  • Cat 11867
  • Human 454
  • Other 16
  • 15
  • Other Canids 14

Top reported reactions (VEDDRA terms, top entries)

  • Emesis 60054
  • Vomiting 51506
  • Lethargy (see also Central nervous system depression in 'Neurological') 23417
  • Lack of efficacy (ectoparasite) - flea 21071
  • UNPALATABLE 17115
  • Lack of efficacy - NOS 13957
  • Diarrhoea 8985
  • INEFFECTIVE, HEARTWORM LARVAE 5672
  • Seizure NOS 5429
  • Lack of efficacy (endoparasite) - heartworm 5093

"Lack of efficacy" terms denote product-performance reports, not adverse reactions.

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-21.json (openFDA animalandveterinary/event.json, pulled 2026-07-21).

Sources

  • openFDA animalandveterinary/event.json (FDA CVM adverse event reports), pulled 2026-07-21